Product
1% plain lidocaine and 0.25% plain bupivacaine
1 clinical trial
2 indications
Indication
Myofascial PainIndication
Myofascial Trigger Point PainClinical trial
Investigating the Minimum Number of Needling Required to Optimize Trigger Point Injections OutcomeStatus: , Estimated PCD: 2024-12-09